Abstract
This study evaluated the clinical efficacy and safety of a new triazolobenzodiazepine, adinazolam, and imipramine in 40 patients with carefully diagnosed major depressive disorder. Overall, adinazolam was found to be as effective as imipramine. In addition, when patients with more severe, melancholic, subtype of depression were examined, adinazolam was also as effective as imipramine. With the exception of sedation, adinazolam patients demonstrated fewer overall adverse events than imipramine subjects. These results suggest that adinazolam may represent an interesting antidepressant compound.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amsterdam JD, Brunswick DJ, Mendels J (1980) Clinical application of tricyclic antidepressant pharmacokinetics and plasma levels. Am J Psychiatry 137:653–662
Bennet IF (1967) Is there a superior antidepressant? In: Garattini S, Duke MNG (eds) Antidepressant drugs, Excerpta Medica, International Congress Series 122, Excerpta Medica, Amsterdam
Bonnet MH, Kramer M, Roth T (1981) A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects. Psychopharmacology 75:258–261
Eberts FS, Philoparlos Y, Reineke LM (1980) Disposition of 14 C-alprazolam, a new anxiolytic antidepressant, in man. Pharmacologist 22:279
Feighner JP, Brauzer B, Gelenberg AJ, Gomez E, Kiev A, Kurland ML, Weiss SS (1979) A placebo controlled multi-center trial of Limbitrol versus its components (amitriptyline and chlordiazepoxide) in the symptomatic treatment of depressive illness. Psychopharmacology 61:217–225
Feighner JP, Aden GC, Fabre LF, Rickels K, Smith WT (1983) Comparison of alprazolam, imipramine and placebo in the treatment of depression. JAMA 249:3057–3064
Feighner JP (1985) Controlled studies of Deracyn (adinazolam mesylate) for major depressive episode. Abstract presented at the NCDEU Annual Meeting (Key Biscayne, Florida)
France RD, Krishnan KRR (1984) Alprazolam-induced manic reaction. Am J Psychiatry 141:127–128
Gall M, Kamdar GV, Collins RJ (1978) Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by simple one-step oxidation of benzodiazepines. J Med Chem 21:1290–1294
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hester JB, Rudzik AD, Von Voightlander PF (1980) 1-(Aminoalkyl)-6-aryl-4H-s-triazolo [4,3a][1,4] benzodiazepines with antianxiety and antidepressant activity. J Med Chem 23:392–397
Lahti RA, Barsuhn C, Hester JB (1983) Pharmacological profile of the antidepressant, adinazolam, a triazolobenzodiazepine. Neuropharmacology 11:1277–1282
Lewis JL, Winokur G (1982) The induction of mania: a natural history study with controls. Arch Gen Psychiatry 39:303–306
Lipman RS, Covi L, Downing RW, Fisher S, Kahn RJ, McNair DM, Rickels, Smith VK (1981) Pharmacotherapy of anxiety and depression. Psychopharmacol Bull 17:91–103
Pyke RE, Cohn JB, Feighner JP, Smith WT (1983) Open-label studies of adinazolam in severe depression Psychopharmacol Bull 19:96–98
Quitkin FM, Rabkin JG, Ross D, Stewart JW (1984) Identification of true drug response to antidepressants. Arch Gen Psychiatry 41:782–786
Rickels K, Cohen D, Csanalosi I, Harris H, Koepke H, Werblowsky J (1982) Alprazolam and imipramine in depressed outpatients: a controlled study. Curr Ther Res 32:157–164
Rickels K (1985) Use of placebo in clinical trials. Psychopharmacol Bull (in press)
Rickels K, Feighner JP, Smith WT (1985) Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry 42:134–141
Schatzberg AF, Cole JO (1978) Benzodiazepines in depressive disorder. Arch Gen Psychiatry 35:1359–1365
Sethy VH, Hodges DH (1982) Role of beta-adrenergic receptors in the antidepressant activity of alprazolam. Res Commun Chem Pathol Pharmacol 36:329–332
Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria. Rationale and reliability. Arch Gen Psychiatry 35:773–782
Turmel A, DeMontigny C (1984) Sensitization of forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine. Eur J Pharmacol 99:241–244
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Amsterdam, J.D., Kaplan, M., Potter, L. et al. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder. Psychopharmacology 88, 484–488 (1986). https://doi.org/10.1007/BF00178511
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00178511